Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
RECURSION PHARMACEUTICALS, INC.
| Metric | RECURSION PHARMACEUTICALS, INC. RXRXHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $75M |
| Net income (latest) | −$645M |
| Operating margin | −867.9% |
| Net margin | −863.4% |
| Return on equity | −57.0% |
| Return on assets | −43.7% |
| Return on capital (ROCE) | −48.9% |
| Debt / equity | 0.30× |
| Revenue growth (YoY) | 26.9% |
| Altman Z″ (distress) | -1.13 |
| Accruals / assets | −18.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.